Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ZD | DRVN |
|---|---|---|
| Price | $55.98 | $11.65 |
| Change today | ▲ 1.41% | ▼ 0.26% |
| Market cap | $1.92B | $1.92B |
| Return, 3 months | +5.1% | -23.0% |
| Return, year to date | +59.3% | -21.4% |
| Return, 1 year | +41.6% | -24.0% |
| P/E (TTM) | 3.2 | 11.7 |
| P/B | 0.9 | 2.3 |
| P/E percentile vs own 5y | 2nd | 63rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +13.7% | +24.5% |
| Analyst buy share | 50% | 22% |
| RSI (14) | 49 | 38 |
| 30-day volatility | 24.7% | 35.8% |
| Max drawdown, 1 year | -33.8% | -39.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
